SNHG17 upregulation is positively correlated with lymph node metastasis and decreased OS in melanoma patients, and SNHG17 expression is an independent predictor of melanoma prognosis. This evidence concerns the gene SNHG17 and metastatic malignant neoplasm in the lymph nodes.